Table 6 Comparison of adverse reactions reported for the branded and generic drugs
Adverse reaction | Case (N) | Present study | Package insert |
|---|---|---|---|
Incidence (%) | Incidence (%) | ||
Increased CPK | 9 | 0.67 | Unknown |
Myalgia | 7 | 0.52 | Unknown |
Rash | 6 | 0.45 | 0.1-1 |
Discomfort | 3 | 0.22 | No documentation |
Myospasm | 2 | 0.15 | <0.1 |
Arrhythmia | 1 | 0.07 | No documentation |
Increased ALP and γ-GTP | 1 | 0.07 | 0.1–1 |
Numbness | 1 | 0.07 | <0.1 |
Malaise | 1 | 0.07 | <0.1 |
Nausea | 1 | 0.07 | <0.1 |
Increased AST and ALT | 1 | 0.07 | Unknown |
Thrombocytopenia | 1 | 0.07 | Unknown |
Anemia (decreased Hb) | 1 | 0.07 | Unknown |
Weakness | 1 | 0.07 | Unknown |
Vertigo | 1 | 0.07 | Unknown |